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Different viruses are detected in the cerebrospinal fluid
(CSF) of HIV-positive patients, with controversial impli-
cations in central nervous system (CNS) impairment.
Objectives: to evaluate the presence, frequency and
associations of Epstein-Barr virus (EB) in the CSF in
HIV-positive patients.
We retrospectively analyzed CSF samples from HIV-
positive adult patients (≥18 years old), with or without
CNS impairment, collected between Oct 2011 and Oct
2012 in a Romanian tertiary infectious diseases hospital.
We performed a multiplex PCR coupled with electro-
spray ionization – time-of-flight mass spectrometry
(Abbott Molecular) which can simultaneously detect:
herpesviruses (1-5 and 8), polyomaviruses, enteroviruses,
adenoviruses and parvoviruses.
The patients were characterized based on the immu-
nological and virological HIV status, neurological find-
ings (including neuroimagery and CSF exam) and
comorbidities.
A number of 55 patients were analyzed, with a mean age
of 33.4 years (31.5 median) and a male:female ratio of
1.9:1. The CD4 count had a mean of 32 (75 median and
IQR=225).
The most frequently detected virus was EB in 20/55
cases.
The EB-positive subgroup had a similar mean age of
33.5 years (median of 31.0) but a different male:female
ratio, of 1.2:1. The CD4 count had a mean of 105.7
(59.5 median and IQR=156).
The following analyses refer to the EB-positive group:
17/20 patients had neurologic impairment. Imagery was
performed in 15 cases and was normal in 5. CSF cellularity
had a median of 2/cmm, IQR=10, CSF-glucose a median
of 48.0 mg/dL, IQR=34 and CSF-protein a median of
55.5mg/dL, IQR=49.5.
In 8/20 cases EB was found as singular agent in the CSF
and in 12/20 it was associated with other microorganisms:
other herpesviruses (3 cases), JC virus (4 cases), Mycobac-
terium tuberculosis (2 cases), Cryptococcus neoformans
(2 cases) and Toxoplasma gondii (one case).
The CSF-HIV viral load was available in 12/20 cases,
being detectable in 10 cases.
Regarding the neurological events (totalizing the neuro-
logical signs/symptoms, CSF exam and imagery), EB was
probably causal in 4/20 cases, possibly causal in another
4/20 cases and was a bystander in 12/20 (3 cases with no
impairment and 9 cases in which the impairments were
strongly attributable to another germ).
EB is the most frequent agent found in the CSF (40%
of HIV-positive cases), mainly in women. It can be
mono-detected but it especially appears in multiple
associations. In more than half of the cases EB acts as
an innocent bystander.
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